Hydroxyzine revealing acquired neuromuscular weakness in a patient with COVID-19 disease

Abdominal hematoma in a patient with Covid-19 infection;Report a case of disease

Introduction: Coagulopathy is a relatively common problem in patients with severe Covid-19. In this study, a hospitalized patient with Covid-19 who developed an abdominal hematoma is introduced. Case Report: The patient was a 46-year-old woman who was hospitalized due to Covid-19. On the fifth day of admission, she developed abdominal pain without gastrointestinal symptoms. Abdominal and pelvic...

Acquired Neuromuscular Weakness in Critical Illness

Neuromuscular Problems in the Patients With COVID-19: A Review Study

Background: SARS-CoV-2 is a member of the betacoronavirus genus that primarily targets the human respiratory system and causes pneumonia-like symptoms. Purpose: This article aims to review neuromuscular problems in patients with COVID-19 based on the available evidence and possible consequences. Methods: In this regard, this narrative review study gathered the related and newest studies publi...

ROY ADAPTATION MODEL IN PATIENT WITH COVID-19

Background & Aims: COVID-19 is an acute disease of the respiratory system with diffuse inflammation. In this disease, a wide range of symptoms can cause biological and psychological changes in performance. Skillful preparation of the patient to find the optimal way to deal with this disease, as well as maintaining the independence and vitality of life, is an important part of the treatment proc...

Hematology findings in patients with Coronavirus disease 2019 (COVID-19)

In December 2019, Wuhan, the capital of Hubei Province in China, became the center of an outbreak of pneumonia with unknown etiology. By 7 January 2020, Chinese scientists have isolated a new coronavirus from patients with viral infectious pneumonia, the Coronavirus 2 Acute Respiratory Syndrome (SARS-CoV-2), previously called 2019-nCoV. The disease was later diagnosed as coronavirus 2019 (COVID...